Safety Endpoints With Vadadustat Versus Darbepoetin Alfa in Patients With Non-Dialysis-Dependent CKD: A Post Hoc Regional Analysis of the PRO2TECT Randomized Clinical Trial of ESA-Treated Patients.
Saved in:
| Title: | Safety Endpoints With Vadadustat Versus Darbepoetin Alfa in Patients With Non-Dialysis-Dependent CKD: A Post Hoc Regional Analysis of the PRO |
|---|---|
| Authors: | Parfrey PS; Department of Medicine, Memorial University, St John's, Newfoundland, Canada., Burke SK; Akebia Therapeutics, Inc., Cambridge, MA., Chertow GM; Stanford University School of Medicine, Palo Alto, CA., Eckardt KU; Department of Nephrology and Medical Intensive Care, Charité-Universitätsmedizin Berlin, Berlin, Germany., Jardine AG; Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK., Lewis EF; Stanford University School of Medicine, Palo Alto, CA., Luo W; Akebia Therapeutics, Inc., Cambridge, MA., Matsushita K; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD., McCullough PA; Cardiorenal Society of America, Phoenix, AZ., Minga T; Akebia Therapeutics, Inc., Cambridge, MA., Winkelmayer WC; Section of Nephrology, Baylor College of Medicine, Houston, TX. |
| Source: | Kidney medicine [Kidney Med] 2023 May 12; Vol. 5 (7), pp. 100667. Date of Electronic Publication: 2023 May 12 (Print Publication: 2023). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101756300 Publication Model: eCollection Cited Medium: Internet ISSN: 2590-0595 (Electronic) Linking ISSN: 25900595 NLM ISO Abbreviation: Kidney Med Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 37427292 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Safety Endpoints With Vadadustat Versus Darbepoetin Alfa in Patients With Non-Dialysis-Dependent CKD: A Post Hoc Regional Analysis of the PRO<subscript>2</subscript>TECT Randomized Clinical Trial of ESA-Treated Patients. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Parfrey+PS%22">Parfrey PS</searchLink>; Department of Medicine, Memorial University, St John's, Newfoundland, Canada.<br /><searchLink fieldCode="AU" term="%22Burke+SK%22">Burke SK</searchLink>; Akebia Therapeutics, Inc., Cambridge, MA.<br /><searchLink fieldCode="AU" term="%22Chertow+GM%22">Chertow GM</searchLink>; Stanford University School of Medicine, Palo Alto, CA.<br /><searchLink fieldCode="AU" term="%22Eckardt+KU%22">Eckardt KU</searchLink>; Department of Nephrology and Medical Intensive Care, Charité-Universitätsmedizin Berlin, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Jardine+AG%22">Jardine AG</searchLink>; Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK.<br /><searchLink fieldCode="AU" term="%22Lewis+EF%22">Lewis EF</searchLink>; Stanford University School of Medicine, Palo Alto, CA.<br /><searchLink fieldCode="AU" term="%22Luo+W%22">Luo W</searchLink>; Akebia Therapeutics, Inc., Cambridge, MA.<br /><searchLink fieldCode="AU" term="%22Matsushita+K%22">Matsushita K</searchLink>; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD.<br /><searchLink fieldCode="AU" term="%22McCullough+PA%22">McCullough PA</searchLink>; Cardiorenal Society of America, Phoenix, AZ.<br /><searchLink fieldCode="AU" term="%22Minga+T%22">Minga T</searchLink>; Akebia Therapeutics, Inc., Cambridge, MA.<br /><searchLink fieldCode="AU" term="%22Winkelmayer+WC%22">Winkelmayer WC</searchLink>; Section of Nephrology, Baylor College of Medicine, Houston, TX. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101756300%22">Kidney medicine</searchLink> [Kidney Med] 2023 May 12; Vol. 5 (7), pp. 100667. <i>Date of Electronic Publication: </i>2023 May 12 (<i>Print Publication: </i>2023). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Inc%22">Elsevier Inc </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101756300 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>2590-0595 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2225900595%22">25900595 </searchLink><i>NLM ISO Abbreviation: </i>Kidney Med <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37427292 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.xkme.2023.100667 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 100667 Titles: – TitleFull: Safety Endpoints With Vadadustat Versus Darbepoetin Alfa in Patients With Non-Dialysis-Dependent CKD: A Post Hoc Regional Analysis of the PRO2TECT Randomized Clinical Trial of ESA-Treated Patients. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Parfrey PS – PersonEntity: Name: NameFull: Burke SK – PersonEntity: Name: NameFull: Chertow GM – PersonEntity: Name: NameFull: Eckardt KU – PersonEntity: Name: NameFull: Jardine AG – PersonEntity: Name: NameFull: Lewis EF – PersonEntity: Name: NameFull: Luo W – PersonEntity: Name: NameFull: Matsushita K – PersonEntity: Name: NameFull: McCullough PA – PersonEntity: Name: NameFull: Minga T – PersonEntity: Name: NameFull: Winkelmayer WC IsPartOfRelationships: – BibEntity: Dates: – D: 12 M: 05 Text: 2023 May 12 Type: published Y: 2023 Identifiers: – Type: issn-electronic Value: 2590-0595 Numbering: – Type: volume Value: 5 – Type: issue Value: 7 Titles: – TitleFull: Kidney medicine Type: main |
| ResultId | 1 |
